Why the study?
The study evaluated the association between left and right atrial echocardiographic parameters and adverse cardiovascular outcomes and death in patients with atrial fibrillation.
Do left and right atrial echocardiographic parameters predict adverse cardiovascular outcomes in patients with atrial fibrillation?
Observational (n=489)
No
Do left and right atrial echocardiographic parameters predict adverse cardiovascular outcomes in patients with atrial fibrillation?
Effect estimate: aHR 1.47 (95% CI 1.03-2.09)
Absolute Event Rate: 35.7% vs 19.2%
p-value: p=0.033
Left atrial volume index and indexed left atrial antero-posterior diameter enhance risk prediction for adverse cardiovascular outcomes in patients with atrial fibrillation.
BACKGROUND: This study evaluates the association between left atrial and right atrial (LA, RA) parameters and a composite endpoint (CEP) of all-cause death, thromboembolism, acute coronary syndrome, and heart failure hospitalization in atrial fibrillation (AF) patients. MATERIAL AND METHODS: Patients were prospectively enrolled. At baseline, the following echocardiogram parameters were measured: LA and RA antero-posterior diameter index (iLAAPD, iRAAPD), LA and RA volume index (LAVi, RAVi), LA and RA sphericity index (LASI, RASI), LA and RA emptying fraction. RESULTS: A total of 489 patients (61.3% males) with a median age of 75 (66-80) years and a median CHA2DS2VASc score of 3 (2-5) were enrolled (92.2% receiving anticoagulation). Permanent AF was present in 40.5% of the total cohort. After a median follow-up of 1114 (392-1384) days, 129 patients (26.3%) reached the CEP. The highest sensitivity for CEP was for LA emptying fraction <28% and iRAAPD >24 mm/m2 (72% and 73%, respectively) while the best negative predictive values were for iLAAPD and LAVi (both 81%). Right atrial parameters were not associated with CEP. Discrimination analysis using net reclassification improvement (NRI) showed that iLAAPD and LAVi significantly improved patient reclassification compared to a null model without atrial parameters (iLAAPD NRI 0.30; P = 0.005; LAVi NRI 0.32; P = 0.002). Multivariate Cox regression analysis found that LA dimensions, volume, and function were associated with a higher risk of adverse outcomes and significantly improved risk prediction for the CEP. CONCLUSIONS: LAVi and iLAAPD enhance discrimination and risk prediction for adverse outcomes in AF patients.
No takes yet. Share an insight, caveat, or question.
Mantovani et al. (2025) conducted an observational in Atrial fibrillation (n=489). Moderate to severe left atrial dilation (LAVi ≥42 ml/m2) vs. No or mild left atrial dilation (LAVi <42 ml/m2) was evaluated on Composite of all-cause death, stroke or systemic embolism, acute coronary syndrome, and hospitalization for new/worsening heart failure (aHR 1.47, 95% CI 1.03-2.09, p=0.033).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: